Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 5/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.58 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.58 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.57 |
| ▸ | HSP90B1 | P14625 | 2/20 | 0.57 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.57 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.57 |
| ▸ | AMD1 | P17707 | 2/20 | 0.55 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.55 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.54 |
| ▸ | NNMT | P40261 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5620786 | 1.00 | AHCY (0.58) | AHCYHIF1ATMEM97SIGMAR1ADORA2B | |
| SCHEMBL5620776 | 1.00 | AHCY (0.58) | AHCYHIF1ATMEM97SIGMAR1ADORA2B | |
| SCHEMBL29385449 | 0.90 | AHCY (0.68) | AHCYHIF1ATMEM97SIGMAR1ADORA2B | |
| SCHEMBL2117335 | 0.90 | AHCY (0.68) | AHCYHIF1ATMEM97SIGMAR1ADORA2B | |
| SCHEMBL1757011 | 0.90 | AHCY (0.68) | AHCYHIF1ATMEM97SIGMAR1ADORA2B | |
| SCHEMBL6902907 | 0.89 | AHCY (0.67) | AHCYHIF1ATMEM97SIGMAR1ADORA2B | |
| SCHEMBL6902895 | 0.89 | AHCY (0.67) | AHCYHIF1ATMEM97SIGMAR1ADORA2B | |
| SCHEMBL6902911 | 0.89 | AHCY (0.67) | AHCYHIF1ATMEM97SIGMAR1ADORA2B | |
| SCHEMBL4520798 | 0.81 | AHCY (0.68) | AHCYHIF1ATMEM97SIGMAR1ADORA2B | |
| SCHEMBL30139992 | 0.81 | AHCY (0.68) | AHCYHIF1ATMEM97SIGMAR1ADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7247621-B2 | Antiviral phosphonate compounds and methods therefor | VALEANT RESEARCH & DEVELOPMENT (US) | 2007-07-24 | — | — | US | disclosed |
| US-20040023921-A1 | Antiviral phosphonate compounds and methods therefor | VRX HOLDCO LLC | 2004-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040023921-A1 | Antiviral phosphonate compounds and methods therefor | POLRMT, CPSF7, RNGTT | AHCY 1598/4885HIF1A 2982/4885TMEM97 1548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.